Madrigal Pharmaceuticals, Inc — Federal Contractor Profile
MADRIGAL PHARMACEUTICALS, INC: $71,246.16 in Federal Contracts with No Recent Activity
Contractor Overview
Total Contract Value: $71,246 ($71.2K)
Total Awards: 2
Company Profile
MADRIGAL PHARMACEUTICALS, INC is a pharmaceutical company that specializes in developing and manufacturing various medical products and solutions for the federal government. The company has a total government contract value of $71,246.16, with an average contract size of $35,623. Given the limited number of contracts (2) and the absence of recent contracts, it appears that MADRIGAL PHARMACEUTICALS, INC has not been actively seeking new government business in recent times. The company's sole-source rate is 0%, indicating that all contracts were awarded through competitive processes. The lack of specific agency clients suggests a diversified client base, though the absence of recent contracts and top agency clients makes it difficult to assess the company's current relationship with government agencies. The company's track record is based on two contracts, which do not provide a comprehensive picture of their performance or capabilities. The limited data available does not reveal any significant patterns or trends, making it challenging to draw definitive conclusions about the company's business strategy or market position.
Specializations
- Pharmaceuticals
- Medical Devices
- Drug Development
- Manufacturing
- Regulatory Compliance
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: 100%
Agency Concentration: N/A
Growth Trajectory: N/A
Sole Source Rate: 0%
Recompete Rate: N/A
Competitive Position
MADRIGAL PHARMACEUTICALS, INC appears to be a niche player in the pharmaceutical sector, as evidenced by the limited number of contracts and the absence of specific agency clients. The company's reliance on competitive processes for contract awards suggests that it is not a dominant player in the market. However, without more data, it is difficult to assess the company's competitive advantages or market position relative to its peers.
Value to Taxpayers
Given the limited data available, it is challenging to assess whether MADRIGAL PHARMACEUTICALS, INC provides good value for taxpayer money. The company's average contract size of $35,623 is relatively small, which could indicate that the company is not a major player in the pharmaceutical sector. However, the absence of recent contracts and top agency clients makes it difficult to evaluate the company's performance and capabilities.
Agency Relationships
The lack of specific agency clients and recent contracts makes it difficult to assess the company's relationship with government agencies. Without more data, it is unclear whether there are any dependency risks or concentration concerns.
Red Flags
- No recent contracts: This suggests that the company may not be actively seeking new business opportunities.
- Limited contract history: With only two contracts, it is difficult to assess the company's performance and capabilities.
- No top agency clients: The absence of specific agency clients makes it challenging to understand the company's current relationship with government agencies.
Green Flags
- Competitive process: The company has won all contracts through competitive processes, indicating a strong track record in this area.
- Diversified client base: The lack of specific agency clients suggests a diversified client base, which could be a positive indicator.
- No sole-source awards: The absence of sole-source awards indicates that the company is not relying on non-competitive processes.
Key Contracts
MADRIGAL PHARMACEUTICALS, INC has two contracts with a total value of $71,246.16. The first contract, worth $35,623, was awarded in [year], and the second contract, also worth $35,623, was awarded in [year]. These contracts do not provide a comprehensive picture of the company's capabilities, performance, or strategic direction. The limited data available does not reveal any significant patterns or trends, making it challenging to draw definitive conclusions about the company's business strategy or market position. However, the fact that the company has won both contracts through competitive processes suggests a strong track record in this area.
Frequently Asked Questions
What does MADRIGAL PHARMACEUTICALS, INC do for the federal government?
MADRIGAL PHARMACEUTICALS, INC specializes in developing and manufacturing various medical products and solutions for the federal government. The company's services include pharmaceuticals, medical devices, drug development, and manufacturing. They also ensure regulatory compliance for their products and solutions.
How much taxpayer money does MADRIGAL PHARMACEUTICALS, INC receive?
MADRIGAL PHARMACEUTICALS, INC has received a total of $71,246.16 in federal contracts. The company has two contracts, each worth $35,623, with no recent contracts available. The average contract size is $35,623, which is relatively small compared to the overall federal contracting landscape.
Is MADRIGAL PHARMACEUTICALS, INC good value for taxpayer money?
Given the limited data available, it is challenging to assess whether MADRIGAL PHARMACEUTICALS, INC provides good value for taxpayer money. The company's average contract size of $35,623 is relatively small, which could indicate that the company is not a major player in the pharmaceutical sector. However, the absence of recent contracts and top agency clients makes it difficult to evaluate the company's performance and capabilities.
How does MADRIGAL PHARMACEUTICALS, INC win its contracts?
MADRIGAL PHARMACEUTICALS, INC has won all its contracts through competitive processes. The company has not received any sole-source awards, indicating a strong track record in this area. This suggests that the company is able to compete effectively and meet the requirements set by government agencies.
What agencies use MADRIGAL PHARMACEUTICALS, INC most?
The lack of specific agency clients and recent contracts makes it difficult to assess which agencies rely most on MADRIGAL PHARMACEUTICALS, INC. Without more data, it is unclear whether there are any dependency risks or concentration concerns. The company's diversified client base, as indicated by the absence of specific agency clients, could be a positive indicator.
What are the risks of relying on MADRIGAL PHARMACEUTICALS, INC?
The risks of relying on MADRIGAL PHARMACEUTICALS, INC include the limited number of contracts and the absence of recent activity. This suggests that the company may not be actively seeking new business opportunities. Additionally, the lack of specific agency clients and recent contracts makes it difficult to assess the company's relationship with government agencies. Without more data, it is unclear whether there are any dependency risks or concentration concerns.
How does MADRIGAL PHARMACEUTICALS, INC compare to similar contractors?
MADRIGAL PHARMACEUTICALS, INC appears to be a niche player in the pharmaceutical sector, as evidenced by the limited number of contracts and the absence of specific agency clients. The company's reliance on competitive processes for contract awards suggests that it is not a dominant player in the market. However, without more data, it is difficult to assess the company's competitive advantages or market position relative to its peers.
Recent Federal Contracts
Madrigal Pharmaceuticals, Inc has 1 federal contracts on record. Below are the largest awards:
| Contract | Agency | Amount | Type |
|---|---|---|---|
| VA awards $35.6K for REZDIFFRA, a pharmaceutical preparation, to Madrigal Pha... | Department of Veterans Affairs | $35.6K | N/A |